Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.19
Delayed Data
As of Jul 29
 +0.02 / +1.71%
Today’s Change
0.64
Today|||52-Week Range
1.97
-15.60%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close1.17
Today’s open1.16
Day’s range1.15 - 1.20
Volume53,897
Average volume (3 months)18,468
Market cap$16.6M
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-29.05%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book3.39

Competitors

 Today’s
change
Today’s
% change
EVOKEvoke Pharma Inc-0.41-13.53%
BVXVBiondVax Pharmaceuti...-0.23-6.41%
ATOSAtossa Genetics Inc-0.01-2.60%
CYANCyanotech Corp+0.07+1.48%
Data as of 3:59pm ET, 07/29/2016

Financials

Last reporting dateMarch 17, 2016
EPS forecast (this quarter)$0.00
Annual revenue (last year)$0.00
Annual profit (last year)-$3.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts

Partner Offers

Search for Jobs